follow us in feedly
StockStreetNews
      • Market Movers
        • Penny Stocks
      • Basic Materials
        • Agriculture
        • Metals & Mining
          • Cobalt
          • Zinc
          • Gold
          • Silver
          • Lithium
          • Uranium
      • Tech
        • Application Software
        • Communications
        • Computer Hardware
        • Online Media
        • Semiconductors
      • Consumer
        • Autos
        • Entertainment
        • Retail
        • Consumer Packaged Goods
        • Tobacco Products
        • Travel & Leisure
      • Financial
        • Asset Management
        • Brokers & Exchanges
        • Credit Services
      • Health
        • Biotechnology
        • Drug Manufacturers
        • Healthcare
        • Pharmaceutical
        • Medical
        • Medical Instruments & Equipment
      • Energy
        • Alternative Energy
        • Solar
        • Oil & Gas
      HomeHealthPharmaceutical

      Pharmaceutical

      Conatus Pharmaceuticals Failed Clinical Trial
      Pharmaceutical

      Conatus Pharmaceuticals Shares Dive After Failed Clinical Trial

      Apr 5 Nicky Toor

      Shares of Conatus Pharmaceuticals (Nasdaq:CNAT) have taken a dive, dropping over 30%, after releasing the results from their Phase 2b clinical trial.

      The POLT-HCV-SVR clinical trial, which studied emiscaran in liver transplant patients …

      Read

      sonama pharmaceuticals fda approval
      Pharmaceutical

      Sonoma Pharmaceuticals FDA Approval – Shares Soar

      Apr 5 Nicky Toor

      California-based Sonoma Pharmaceuticals (Nasdaq:SNOA) has received approval from the US Food and Drug Administration (FDA) for their antimicrobial post-therapy gel.

      Shares of the company soared this morning after the announcement and, currently, the …

      Read

      Biopharm Stocks
      Pharmaceutical

      Top Biopharm Stocks Today: Here’s What Investors Should Know

      Apr 4 Ed Browne

      As usual, biopharm stocks dominate the top of the small-cap stock gainers list today.

      Yahoo Finance

       

      Vericel (NASDAQ:VCEL)

      Share price: $11.15 | 24h change: 15.54%  | …

      Read

      Health

      Dermira Stocks Plummet Over -65% Over Drug Failure

      Mar 5 Ed Browne

      Stocks in Biopharmaceutical company Dermira have plummeted nearly -65% over the weekend on reports that its acne drug olumacostat glasaretil has failed it’s Phase 3 trials. 

      In a news release, Dermira announced that …

      Read

      Pharmaceutical

      Best Pharma Stocks Today: Cascadian Therapeutics Up Over 70%

      Jan 31 Ed Browne

      Looking for the best pharma stocks to invest in today? One of the biggest gainers by far is Cascadian Therapeutics, which, with a current share price of $10.09 USD, has been soaring with a 24-hour …

      Read

      Achaogen
      Pharmaceutical

      Achaogen Stock Climbing After Positive Trial Outcome

      Jan 30 Ed Browne

      Share prices in late-stage biopharmaceutical company Achaogen (NASDAQ:AKAO) Inc. took a sharp rise today on the heels of news that the FDA positively inspected a manufacturing plant associated with the production of its drug plazomicin. …

      Read

      Pharmaceutical

      New Strong Buy Stocks for December 14th

      Dec 14 Nataly Timchenko

      Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

      Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increased …

      Read

      Pharmaceutical

      Why Sangamo Therapeutics (SGMO) Could Be Positioned for a Surge

      Dec 14 Nataly Timchenko

      Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is a clinical-stage biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity …

      Read

      Anavex Life Sciences Corp.
      Pharmaceutical

      A Look at Anavex Life Sciences Corp.’s Current Standings

      Nov 14 Jen Jiang

      Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The company’s lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX2-73 with donepezil, ANAVEX 19-144, ANAVEX …

      Read

      Impax Laboratories Inc.
      Pharmaceutical

      Impax Laboratories Inc. Plunges 5.74% During Monday Trading

      Nov 14 Jen Jiang

      As of Monday trading on November 13th, Impax Laboratories Inc. (NASDAQ:$IPXL) plunged a cool 5.74%, or a loss of $-1.05 per share, to close at $17.25.

      Impax Laboratories is a pharmaceutical company, developing …

      Read

      Posts navigation

      1 2 3 »

      YOU MAY ALSO LIKE

      • New Wave Esports Hits the Market Ready to Deliver Capital and Support Services to the Esports Industry
        Nov 7 stockstreetnews
      • BevCanna Signs Definitive Agreement for Outdoor Cannabis Cultivation
        Sep 17 BevCanna Enterprises Inc
      • LiteLink Signs Trial And Customer Agreement with Large Canadian Nursery Leader, Strengthening Its Position in the Live Product Logistics Industry
        Sep 11 stockstreetnews
      • Stillcanna Moves Towards Commercial Operations With Arrival Of New Harvester And Nears Completion Of Polish Nexus Extraction Facility
        Aug 20 StillCanna
      • BevCanna Announces Successful Testing of Cannabis Powder Technology
        Aug 14 BevCanna Enterprises Inc
      Subscribe & Get The LATEST Stock Pick Alerts
      Advertise With Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2019 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2019 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767